Skip to main content
SpringerLink
Log in

Update hormonelle Kontrazeption

Update hormonal contraception

  • Gynäkologie aktuell
  • Published:
Der Gynäkologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. de Bastos M, Stegeman BH, Rosendaal FR et al (2014) Combined oral contraceptives: venous thrombosis. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD010813.pub2

    Article  PubMed  Google Scholar 

  2. Baum JK, Bookstein JJ, Holtz F, Klein EW (1973) Possible association between benign hepatomas and oral contraceptives. Lancet 302:926–929. https://doi.org/10.1016/S0140-6736(73)92594-4

    Article  Google Scholar 

  3. Beral V, Doll R, Hermon C et al (2008) Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controls. Lancet. https://doi.org/10.1016/S0140-6736(08)60167-1

    Article  PubMed  Google Scholar 

  4. Bode H, Heßling AJ (2015) Die Perspektive der 14-bis 25-Jährigen. Ergebnisse einer aktuellen Repräsentativen Wiederholungsbefragung. Bundeszentrale für gesundheitliche Aufklärung, Köln

    Google Scholar 

  5. Brahmi D, Curtis KM (2013) When can a woman start combined hormonal contraceptives (CHCs)?: a systematic review. Contraception 87:524–538. https://doi.org/10.1016/j.contraception.2012.09.010

    Article  PubMed  Google Scholar 

  6. Coffee AL, Kuehl TJ, Willis S, Sulak PJ (2006) Oral contraceptives and premenstrual symptoms: comparison of a 21/7 and extended regimen. Am J Obstet Gynecol 195:1311–1319. https://doi.org/10.1016/j.ajog.2006.05.012

    Article  CAS  PubMed  Google Scholar 

  7. Collaborative Group on Epidemiological Studies on Endometrial Cancer (2015) Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27 276 women with endometrial cancer from 36 epidemiological studies. Lancet Oncol 16:1061–1070. https://doi.org/10.1016/S1470-2045(15)00212-0

    Article  CAS  Google Scholar 

  8. Dominick S, Hickey M, Chin J, Su HI (2015) Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD007245.pub3

    Article  PubMed  PubMed Central  Google Scholar 

  9. Edelman A, Micks E, Gallo MF et al (2014) Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD004695.pub3

    Article  PubMed  PubMed Central  Google Scholar 

  10. Edwards SM, Zieman M, Jones K et al (2008) Initiation of oral contraceptives—start now! J Adolesc Health 43:432–436. https://doi.org/10.1016/j.jadohealth.2008.06.008

    Article  PubMed  Google Scholar 

  11. FSRH (2017) FSRH guideline: contraception for women aged over 40 years

    Google Scholar 

  12. Gallo MF, Lopez LM, Grimes DA et al (2014) Combination contraceptives: effects on weight. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD003987.pub5

    Article  PubMed  PubMed Central  Google Scholar 

  13. Gemzell-Danielsson K, Berger C et al (2013) Emergency contraception—mechanisms of action. Contraception 87:300–308. https://doi.org/10.1016/j.contraception.2012.08.021

    Article  CAS  PubMed  Google Scholar 

  14. Grimes DA, Jones LB, Lopez LM, Schulz KF (2014) Oral contraceptives for functional ovarian cysts. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD006134.pub5

    Article  PubMed  PubMed Central  Google Scholar 

  15. Hannaford PC, Iversen L, Macfarlane TV et al (2010) Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners’ Oral Contraception Study. BMJ 340:c927–c927. https://doi.org/10.1136/bmj.c927

    Article  PubMed  PubMed Central  Google Scholar 

  16. Healthcare FFSR (2016) Uk medical eligibility for contraceptive use 2016

    Google Scholar 

  17. Hee L, Kettner LO, Vejtorp M (2013) Continuous use of oral contraceptives: an overview of effects and side-effects. Acta Obstet Gynecol Scand 92:125–136. https://doi.org/10.1111/aogs.12036

    Article  CAS  PubMed  Google Scholar 

  18. Heinemann LAJ, Dinger JC (2007) Range of published estimates of venous thromboembolism incidence in young women. Contraception 75:328–336. https://doi.org/10.1016/j.contraception.2006.12.018

    Article  PubMed  Google Scholar 

  19. Hua J (2014) Levonorgestrel-releasing intrauterine system versus medical therapy for menorrhagia: a systematic review and meta-analysis. Med Sci Monit 20:1700–1713. https://doi.org/10.12659/MSM.892126

    Article  PubMed  PubMed Central  Google Scholar 

  20. Kapp N, Curtis KM (2009) Hormonal contraceptive use among women with liver tumors: a systematic review. Contraception 80:387–390. https://doi.org/10.1016/j.contraception.2009.01.021

    Article  CAS  PubMed  Google Scholar 

  21. Klok FA, Barco S (2019) Optimal management of hormonal contraceptives after an episode of venous thromboembolism. Thromb Res 181:S1–S5. https://doi.org/10.1016/S0049-3848(19)30357-3

    Article  CAS  PubMed  Google Scholar 

  22. Lopez LM, Grey TW, Stuebe AM et al (2015) Combined hormonal versus nonhormonal versus progestin-only contraception in lactation. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD003988.pub2

    Article  PubMed  PubMed Central  Google Scholar 

  23. Lopez LM, Grimes DA, Schulz KF et al (2014) Steroidal contraceptives: effect on bone fractures in women. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD006033.pub5

    Article  PubMed  PubMed Central  Google Scholar 

  24. Lopez LM, Newmann SJ, Grimes DA et al (2012) Immediate start of hormonal contraceptives for contraception. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD006260.pub3

    Article  PubMed  PubMed Central  Google Scholar 

  25. Lurie G, Wilkens LR, Thompson PJ et al (2008) Combined oral contraceptive use and epithelial ovarian cancer risk. Epidemiology 19:237–243. https://doi.org/10.1097/EDE.0b013e31816334c5

    Article  PubMed  Google Scholar 

  26. Martínez F, Ramírez I, Pérez-Campos E et al (2012) Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis. Eur J Contracept Reprod Health Care 17:7–29. https://doi.org/10.3109/13625187.2011.643836

    Article  CAS  PubMed  Google Scholar 

  27. Mathieu D, Kobeiter H, Maison P et al (2000) Oral contraceptive use and focal nodular hyperplasia of the liver. Gastroenterology 118:560–564. https://doi.org/10.1016/S0016-5085(00)70262-9

    Article  CAS  PubMed  Google Scholar 

  28. Mørch LS, Skovlund CW, Hannaford PC et al (2017) Contemporary hormonal contraception and the risk of breast cancer. N Engl J Med 377:2228–2239. https://doi.org/10.1056/NEJMoa1700732

    Article  PubMed  Google Scholar 

  29. Nappi C, Bifulco G, Tommaselli GA et al (2012) Hormonal contraception and bone metabolism: a systematic review. Contraception 86:606–621. https://doi.org/10.1016/j.contraception.2012.04.009

    Article  CAS  PubMed  Google Scholar 

  30. Nappi RE, Kaunitz AM, Bitzer J (2016) Extended regimen combined oral contraception: a review of evolving concepts and acceptance by women and clinicians. Eur J Contracept Reprod Health Care 21:106–115. https://doi.org/10.3109/13625187.2015.1107894

    Article  CAS  PubMed  Google Scholar 

  31. Nightingale AL, Lawrenson RA, Simpson EL et al (2000) The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptives. Eur J Contracept Reprod Health Care 5:265–274. https://doi.org/10.1080/13625180008500402

    Article  CAS  PubMed  Google Scholar 

  32. Pagano HP, Zapata LB, Berry-Bibee EN et al (2016) Safety of hormonal contraception and intrauterine devices among women with depressive and bipolar disorders: a systematic review. Contraception 94:641–649. https://doi.org/10.1016/j.contraception.2016.06.012

    Article  CAS  PubMed  Google Scholar 

  33. Pastor Z, Holla K, Chmel R (2013) The influence of combined oral contraceptives on female sexual desire: a systematic review. Eur J Contracept Reprod Health Care 18:27–43. https://doi.org/10.3109/13625187.2012.728643

    Article  CAS  PubMed  Google Scholar 

  34. Roach REJ, Helmerhorst FM, Lijfering WM et al (2015) Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD011054.pub2

    Article  PubMed  PubMed Central  Google Scholar 

  35. Royal College of Obstetricians and Gynaecologists (2010) Venous thromboembolism and hormonal contraception. Green top Guideline No. 40. RCOG Press, London, UK

    Google Scholar 

  36. Sacco S, Merki-Feld GS, Ægidius KL et al (2017) Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC). J Headache Pain 18:108. https://doi.org/10.1186/s10194-017-0815-1

    Article  PubMed  PubMed Central  Google Scholar 

  37. Shen J, Che Y, Showell E et al (2019) Interventions for emergency contraception. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD001324.pub6

    Article  PubMed  PubMed Central  Google Scholar 

  38. Tepper NK, Whiteman MK, Marchbanks PA et al (2016) Progestin-only contraception and thromboembolism: a systematic review. Contraception 94:678–700. https://doi.org/10.1016/j.contraception.2016.04.014

    Article  CAS  PubMed  Google Scholar 

  39. Visser J, Snel M, Van Vliet HAAM (2013) Hormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD003990.pub4

    Article  PubMed  PubMed Central  Google Scholar 

  40. Weill A, Dalichampt M, Raguideau F et al (2016) Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study. BMJ. https://doi.org/10.1136/bmj.i2002

    Article  PubMed  PubMed Central  Google Scholar 

  41. World Health Organisation (2015) Medical eligibility criteria for contraceptive use, 5. Aufl.

    Google Scholar 

  42. van Zuuren EJ, Fedorowicz Z, Carter B, Pandis N (2015) Interventions for hirsutism (excluding laser and photoepilation therapy alone). Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD010334.pub2

    Article  PubMed  PubMed Central  Google Scholar 

  43. Cleland K, Haoping Z, Goldstuck N (2012) The efficacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience. Hum Reprod 27:1994–2000. https://doi.org/10.1093/humrep/des140

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Gynäkologie und Geburtshilfe, St. Franziskus-Hospital Münster, Münster, Deutschland

    Linda S. Ross

  2. Abteilung Gynäkologische Endokrinologie, Universitätsklinikum Bern, Bern, Schweiz

    Petra Stute

  3. Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Deutschland

    Ludwig Kiesel

Authors
  1. Linda S. Ross
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Petra Stute
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ludwig Kiesel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ludwig Kiesel.

Ethics declarations

Interessenkonflikt

L.S. Ross, P. Stute und L. Kiesel geben an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Additional information

Redaktion

T. Fehm, Düsseldorf

L. Kiesel, Münster

R. Kimmig, Essen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ross, L.S., Stute, P. & Kiesel, L. Update hormonelle Kontrazeption. Gynäkologe 54, 116–120 (2021). https://doi.org/10.1007/s00129-020-04726-9

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00129-020-04726-9

Search

Navigation